ArticleMedicine2026
Trends in mortality rates for musculoskeletal and connective tissue diseases.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The burden of the musculoskeletal system and connective tissue poses a significant public health challenge in the United States. Musculoskeletal diseases and connective tissue diseases independently contribute to high morbidity and mortality rates. This study seeks to investigate mortality trends associated with the simultaneous occurrence of the musculoskeletal system and connective tissue among the US population over the period from 1999 to 2020. Centers for Disease Control and Prevention's Wide-Ranging Online Data for Epidemiologic Research was used to identify the musculoskeletal system and connective tissue-related deaths that occurred within the United States from 1999 to 2020. Crude and age-adjusted mortality rates (AAMRs) were calculated, as well as annual percent change and weighted average annual percent change with 95% confidence intervals for the AAMRs. The Joinpoint Regression Program was used to determine trends in mortality within the study period. Joinpoint regression analysis was employed to determine annual percentage changes and assess statistical significance (P < .05). From 1999 to 2020, female patients demonstrated greater mortality rates from the musculoskeletal system and connective tissue compared with males. When stratified by race and ethnicity, Black patients had the highest AAMR over the study period at 9.50 per 100,000 people in 1999. Additionally, AAMRs were consistently higher in rural areas compared with urban locations. By age group, patients aged 85+ years had the highest overall crude mortality rate at 91.20 per 100,000 people in 1999, with the lowest rate in ages 25 to 34 years at 0.70 per 100,000 people in 1999. This study expands upon previously reported trends in musculoskeletal system and connective tissue-related mortality, highlighting epidemiological differences in musculoskeletal system and connective tissue-related death. Significant disparities in mortality rates were noted in older-aged, female, Black, and rural patients. Targeted public health strategies concerning the unique needs of these diverse populations will be essential in improving mortality rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.